LifeVantage Corporation (LFVN) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

LifeVantage Corporation (LFVN) Consumer Business Overview

LifeVantage Corporation develops and distributes science-backed nutrigenomic activators, supplements, and skincare products via direct sales and online channels. With a global presence in key markets, the company focuses on leveraging independent distributors to drive sales and expand its reach within the competitive packaged foods sector.

What Is the Investment Thesis for LFVN?

LifeVantage Corporation presents a mixed investment case. The company's high gross margin of 78.1% indicates strong pricing power and efficient cost management. Its dividend yield of 3.37% offers an income stream for investors. However, the company's market capitalization of $80.4M suggests it is a small-cap stock, which can be subject to higher volatility. The P/E ratio of 15.93 indicates that the company may be undervalued compared to its earnings. Growth catalysts include expansion into new international markets and the introduction of new, scientifically backed products. A potential risk is the reliance on a direct selling model, which can be sensitive to regulatory changes and distributor attrition. The company's beta of 0.39 suggests lower volatility compared to the broader market.

Based on FMP financials and quantitative analysis

LFVN Key Highlights

Market Cap of $80.4M reflects its small-cap status within the Consumer Defensive sector.

• P/E ratio of 15.93 indicates a potentially undervalued stock relative to its earnings.
• Gross Margin of 78.1% demonstrates strong pricing power and efficient cost management.
• Dividend Yield of 3.37% provides an attractive income stream for investors.
• Beta of 0.39 suggests lower volatility compared to the broader market, offering some stability.

Who Are LFVN's Competitors?

LFVN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are LFVN's Key Strengths?

Proprietary nutrigenomic technology and patented formulations.

• Established network of independent distributors.
• Strong brand reputation and customer loyalty.
• High gross profit margins.

What Are LFVN's Weaknesses?

Reliance on direct selling model, which can be sensitive to regulatory changes.

• Small market capitalization and limited financial resources.
• Dependence on a relatively small number of key products.
• Potential for distributor attrition and compliance issues.

What Could Drive LFVN Stock Higher?

Launch of new nutrigenomic products targeting specific health concerns (e.g., cognitive function, immune support).

• Expansion into new international markets, particularly in Asia and South America.
• Increased investment in digital marketing and social media to drive online sales.
• Strengthening relationships with independent distributors through training and incentives.

What Are the Key Risks for LFVN?

Inconsistent delivery — missed Wall Street EPS estimates in 3 of the last 8 reported quarters.

• Regulatory changes affecting the direct selling industry and dietary supplements.
• Product liability claims and adverse publicity related to product safety or efficacy.
• Competition from larger, more established players in the health and wellness market.
• Economic downturns and fluctuations in currency exchange rates affecting international sales.

What Are the Growth Opportunities for LFVN?

• Expansion into New International Markets: LifeVantage has the opportunity to expand its presence in underserved international markets. Focusing on regions with a growing interest in health and wellness, such as Southeast Asia and South America, could significantly increase revenue. Tailoring products to local preferences and regulatory requirements will be crucial for success. The global dietary supplements market is projected to reach $230.73 billion by 2027, providing a substantial market opportunity.
• Development of New Nutrigenomic Products: Investing in research and development to create new, scientifically validated nutrigenomic products can drive growth. Focusing on specific health concerns, such as cognitive function, immune support, and healthy aging, can attract new customer segments. Collaborating with research institutions and universities can enhance the credibility and effectiveness of these products. The nutrigenomics market is expected to grow as consumers seek personalized health solutions.
• Enhancement of Online Sales Channels: Improving the user experience and functionality of its e-commerce platform can drive online sales. Investing in digital marketing and social media campaigns can increase brand awareness and attract new customers. Offering personalized product recommendations and subscription services can enhance customer loyalty. The online channel is a rapidly growing segment of the dietary supplements market, offering significant growth potential.
• Strengthening Relationships with Independent Distributors: Providing ongoing training, support, and incentives to its network of independent distributors can improve sales performance and retention. Implementing a robust distributor management system can streamline operations and enhance communication. Recognizing and rewarding top-performing distributors can motivate the sales force. The direct selling model remains a key component of LifeVantage's growth strategy.
• Strategic Partnerships and Acquisitions: Forming strategic partnerships with complementary businesses, such as fitness centers, wellness clinics, and healthcare providers, can expand its reach and credibility. Acquiring smaller companies with innovative products or technologies can accelerate growth and diversify its product portfolio. Careful due diligence and integration planning are essential for successful partnerships and acquisitions. This can provide access to new markets and technologies.

What Are LFVN's Competitive Advantages?

• Proprietary Formulations: Patented and scientifically validated formulas provide a competitive edge.
• Direct Selling Network: Established network of independent distributors fosters customer loyalty and personalized engagement.
• Brand Reputation: Strong brand recognition and trust built on scientific research and product efficacy.
• Recurring Revenue: Subscription services and customer loyalty programs generate predictable revenue streams.

What Does LFVN Do?

LifeVantage Corporation, headquartered in Lehi, Utah, was founded with a focus on developing and marketing innovative health and wellness products. The company's core business revolves around nutrigenomics, the science of using nutrition to influence gene expression. Its flagship product, Protandim, is a dietary supplement designed to combat oxidative stress through Nrf2 activation. Over the years, LifeVantage has expanded its product line to include a range of dietary supplements, including LifeVantage Omega+, LifeVantage ProBio, and Petandim for Dogs, catering to both human and pet health needs. The company also offers weight management products under the PhysIQ brand and a comprehensive line of skincare and haircare products under the TrueScience brand. LifeVantage distributes its products through a network of independent distributors and its e-commerce platform, reaching customers in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. This direct selling model allows for personalized customer engagement and education about the science behind its products. LifeVantage continues to invest in research and development to innovate and expand its product offerings in the health and wellness market.

What Products and Services Does LFVN Offer?

• Develops and markets nutrigenomic activators designed to influence gene expression.
• Offers dietary supplements targeting oxidative stress, digestive health, and overall wellness.
• Provides weight management products under the PhysIQ brand.
• Sells skincare and haircare products under the TrueScience brand.
• Distributes products through a network of independent distributors.
• Operates an e-commerce platform for direct sales to consumers.
• Conducts research and development to innovate new health and wellness solutions.

How Does LFVN Make Money?

• Develops and patents proprietary formulations for nutrigenomic products.
• Sells products through a direct selling network of independent distributors.
• Generates revenue through online sales via its e-commerce platform.
• Focuses on recurring revenue through subscription services and customer loyalty programs.

What Industry Does LFVN Operate In?

LifeVantage Corporation operates in the competitive packaged foods and dietary supplements industry, which is characterized by increasing consumer interest in health and wellness. The global dietary supplements market is expected to continue growing, driven by rising healthcare costs and an aging population. Key trends include a shift towards personalized nutrition and the increasing popularity of online sales channels. LifeVantage differentiates itself through its focus on nutrigenomics and scientifically validated products. However, it faces competition from larger, more established players in the packaged foods and supplement industries, as well as other direct selling companies.

Who Are LFVN's Key Customers?

• Health-conscious consumers seeking natural and scientifically validated products.
• Individuals looking for solutions to combat oxidative stress and promote healthy aging.
• Customers interested in weight management and improved digestive health.
• Independent distributors who purchase products for personal use and resale.

Over the past six months, LifeVantage Corporation insiders filed 12 SEC Form 4 transactions — 8 sales and 4 purchases. On net that is roughly 823K shares acquired (about $156K) — insiders putting money in tends to read as conviction.

LifeVantage Corporation has missed Wall Street's EPS estimate in 3 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 10.9% above estimates on average.

LifeVantage Corporation's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 3.01 places it in the safe zone, indicating low near-term bankruptcy risk.

Return on equity for LifeVantage Corporation stands at 17.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 9.3%, showing how much profit it generates from its asset base. LFVN trades at a trailing price-to-earnings ratio of 15.93, below the Consumer Defensive sector average of ~27.60x. Its free cash flow yield is 4.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.96 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 7.2%, the inverse of the P/E and a quick read on earnings relative to price.

LifeVantage Corporation (LFVN) Valuation Context

Valued at $80.4M, LFVN is classified as a micro-cap stock. Analyst price targets span from $6.00 to $6.00, with a consensus of $6.00. At the current price of $6.37, that implies roughly 6% downside from the consensus target. Relative to its peer group, LFVN's quantitative score of 61/100 is roughly in line with the peer average of 55/100.

LFVN Revenue & Earnings Trend

In Q4 FY2026, LFVN generated $42.4M in top-line revenue, marking a sequential decrease of 3.1%. The company recorded net income of $1.3M, with diluted EPS of $0.10. Revenue has contracted over three consecutive quarters, which investors in this micro-cap Consumer Defensive stock should monitor closely. Across the four most recent quarters, LFVN averaged $0.10 in diluted EPS.

Company Profile

LifeVantage Corporation operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Lehi, US. The company is led by CEO Terrence Moorehead. LFVN has traded publicly since 1994.

LFVN Financials

LFVN Latest News

LFVN Analyst Consensus

LFVN MoonshotScore

Latest LifeVantage Corporation Analysis

LFVN Consumer Defensive Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources